title: Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.
authors.affiliation: ARC Epidemiology Unit, Manchester University Medical School, UK. a.silman@manchester.ac.uk
authors.forename: J P
authors.initials: JP
authors.lastname: Franklin
authors.forename: D P M
authors.initials: DP
authors.lastname: Symmons
authors.forename: A J
authors.initials: AJ
authors.lastname: Silman
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D008223:Lymphoma / Q000139:chemically induced*; D018570:Risk Assessment; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha